Director/Senior Director, EMEA Health Economics and Outcomes Research (HEOR) Leader
Scholar Rock
·Today
- Location
- Zug
- Workplace
- Hybrid
- Type
- Full-time
- Department
- Commercial
- Seniority
- Director
- Experience
- 8+ years
- Education
- Master
- Source
- Lever
Description
Scholar Rock is delivering muscle-targeted breakthroughs to transform the treatment of spinal muscular atrophy (SMA) and other rare neuromuscular diseases where muscle atrophy remains a critical unmet need.
As a global leader in myostatin biology, a field focused on proteins that regulate muscle mass, the biopharmaceutical company is named for the visual resemblance of a scholar rock to protein structures. Our commitment to unlock fundamentally different treatment approaches is powered by broad application of a proprietary platform, which has developed novel monoclonal antibodies to modulate protein growth factors with extraordinary selectivity. Scholar Rock works every day to create new possibilities for patients through its highly innovative anti-myostatin program, including opportunities in additional rare neuromuscular diseases. Learn more about our neuromuscular franchise at ScholarRock.com and follow @ScholarRock on X and on LinkedIn.
The Director/Senior Director, EMEA Health Economics and Outcomes Research (HEOR) Leader, reporting to the Vice President Global Medical Affairs, will lead the development and execution of the go-to market strategy and deliverables to support value of apitegromab as well as the clinical stage Scholar Rock portfolio, in close partnership with the cross-functional matrix team.
This individual will serve as the strategic leader and subject matter expert for EMEA HEOR, responsible for country-level budget impact and cost-effectiveness model adaptations, evidence generation plans, and value communications required to support the national health technology assessment (HTA), payer dossiers, EU Joint Clinical Assessment (JCA), and reimbursement negotiations of Scholar Rock treatments. The role requires strong strategic leadership and cross-functional collaboration with Medical Affairs, Market Access, Commercial, Clinical Development and the regional teams in EMEA to optimize access and reimbursement for patients worldwide.
The successful candidate will develop strategic partnerships and research collaborations with external experts, healthcare policymakers, payers and various academic centers to support the strategy for apitegromab and future products.